Near-drowning-associated Aeromonas pneumonia.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 8969997)

Published in J Emerg Med on March 06, 1997

Authors

P T Ender1, M J Dolan, D Dolan, J C Farmer, G P Melcher

Author Affiliations

1: Department of Infectious Diseases, Wilford Hall Medical Center, Lackland Air Force Base, Texas 78236-5300, USA.

Articles by these authors

Relapsing illness due to Rochalimaea henselae in immunocompetent hosts: implication for therapy and new epidemiological associations. Clin Infect Dis (1992) 3.61

Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci U S A (1999) 3.21

Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother (2004) 3.09

Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol (1990) 2.99

Bartonella henselae neuroretinitis in cat scratch disease. Diagnosis, management, and sequelae. Ophthalmology (1998) 2.43

Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science (1993) 2.35

Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A (2001) 2.35

Nosocomial Legionnaires' disease: aspiration as a primary mode of disease acquisition. Am J Med (1993) 2.08

Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J Biol Chem (2000) 2.05

Ultrasound guidance improves the success rate of internal jugular vein cannulation. A prospective, randomized trial. Chest (1990) 2.02

Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med (1998) 2.01

Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis (1995) 1.97

Molecular genotyping of methicillin-resistant Staphylococcus aureus via fluorophore-enhanced repetitive-sequence PCR. J Clin Microbiol (1995) 1.92

Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann Intern Med (1993) 1.79

A close look at alcohol gel as an antimicrobial sanitizing agent. Am J Infect Control (1999) 1.71

In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis (1995) 1.69

Legionnaires' disease in human immunodeficiency virus-infected patients: eight cases and review. Clin Infect Dis (1994) 1.59

Pneumonia associated with near-drowning. Clin Infect Dis (1997) 1.42

Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus. J Infect Dis (2001) 1.38

Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis (1996) 1.36

Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J Infect Dis (1992) 1.30

Neuroretinitis, aseptic meningitis, and lymphadenitis associated with Bartonella (Rochalimaea) henselae infection in immunocompetent patients and patients infected with human immunodeficiency virus type 1. Clin Infect Dis (1995) 1.29

Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. J Immunol (1999) 1.23

A case-control study of cancers of the nasal cavity and paranasal sinuses. Am J Epidemiol (1984) 1.23

Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons. J Infect Dis (1996) 1.22

Bilateral cochlear implants controlled by a single speech processor. Am J Otol (1998) 1.18

Demonstration, by immunoelectronmicroscopy, of a cell wall antigen in Trichosporon beigelii that cross-reacts with Cryptococcus neoformans capsular polysaccharide. J Infect Dis (1988) 1.13

Significant infections due to Bacillus species following abrasions associated with motor vehicle-related trauma. Clin Infect Dis (1992) 1.12

Giant cell arteritis and polymyalgia rheumatica. Review for the otolaryngologist. Ann Otol Rhinol Laryngol (1987) 1.12

Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS (1996) 1.09

Management of amyloidosis of the larynx and trachea. Arch Otolaryngol (1982) 1.06

Infections due to Trichosporon species: new concepts in mycology, pathogenesis, diagnosis and treatment. Curr Top Med Mycol (1993) 1.04

Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus. J Infect Dis (1988) 1.04

Human immunodeficiency virus infection in the US Air Force: seroconversions, clinical staging, and assessment of a T helper cell functional assay to predict change in CD4+ T cell counts. J Infect Dis (1991) 1.04

Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity. J Virol (1992) 1.04

Laryngeal radionecrosis and hyperbaric oxygen therapy: report of 18 cases and review of the literature. Ann Otol Rhinol Laryngol (2000) 1.04

Hyperoxic myopia. Trans Am Ophthalmol Soc (1978) 1.03

A chemically defined liquid medium that supports primary isolation of Rochalimaea (Bartonella) henselae from blood and tissue specimens. J Clin Microbiol (1995) 1.03

Vertebral artery occlusion associated with cervical spine trauma. A prospective analysis. Spine (Phila Pa 1976) (1997) 1.01

An outbreak of influenza a caused by imported virus in the United States, July 1999. Clin Infect Dis (2001) 1.01

Temporal arteriography and immunofluorescence as diagnostic tools in temporal arteritis. J Rheumatol (1977) 0.98

Serum levels of virus burden in early-stage human immunodeficiency virus type 1 disease in women. J Infect Dis (1997) 0.98

Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects. J Infect Dis (1993) 0.96

Transmission of cerebrospinal fluid pressure via the cochlear aqueduct and endolymphatic sac. Am J Otolaryngol (1983) 0.94

HIV-1 infection induces a selective reduction in STAT5 protein expression. J Immunol (1998) 0.92

Occurrence of human papillomavirus and p53 gene mutations in Kaposi's sarcoma. Virology (1994) 0.92

Comparison by race of total serum IgG, IgA, and IgM with CD4+ T-cell counts in North American persons infected with the human immunodeficiency virus type 1. J Acquir Immune Defic Syndr (1992) 0.91

Hyperbaric oxygen therapy for laryngeal radionecrosis. Ann Otol Rhinol Laryngol (1987) 0.90

Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J Infect Dis (1995) 0.90

Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects. J Infect Dis (2001) 0.89

Hypopnea associated with acetate hemodialysis: carbon dioxide-flow-dependent ventilation. N Engl J Med (1981) 0.88

Comparative studies of speech processing strategies for cochlear implants. Laryngoscope (1988) 0.88

Limiting dilution analysis of interleukin-2-producing T cells responsive to recall and alloantigens in human immunodeficiency virus-infected and uninfected individuals. Eur J Immunol (1993) 0.88

Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates. J Clin Microbiol (1995) 0.87

Production of a murine monoclonal antibody that recognizes an epitope specific to Coccidioides immitis antigen 2. Infect Immun (1993) 0.86

CT diagnosis of actinomycosis of the neck. J Comput Assist Tomogr (1984) 0.85

Serum IgE levels in 622 persons with human immunodeficiency virus infection: IgE elevation with marked depletion of CD4+ T-cells. AIDS Res Hum Retroviruses (1990) 0.85

Association of Bartonella species and Coxiella burnetii infection with coronary artery disease. J Infect Dis (2001) 0.85

CD38 expression on cryopreserved CD8+ T cells predicts HIV disease progression. Cytometry (1998) 0.85

Pressure transfer between the perilymph and the cerebrospinal fluid compartments in cats. Am J Otol (1992) 0.85

Coccidioides immitis presenting as a mycelial pathogen with empyema and hydropneumothorax. J Med Vet Mycol (1992) 0.85

Quality framework for force plate testing. Proc Inst Mech Eng H (1997) 0.84

Cytokine induction in human coccidioidomycosis. Infect Immun (1994) 0.84

Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation. J Virol (2000) 0.84

In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol (1997) 0.83

Seminal plasma RANTES levels positively correlate with seminal plasma HIV-1 RNA levels. AIDS (1999) 0.83

Static in situ calibration of force plates. J Biomech (1996) 0.82

Beta-chemokines inhibit activation-induced death of lymphocytes from HIV-infected individuals. Eur J Immunol (2000) 0.82

Diving injuries to the inner ear. Ann Otol Rhinol Laryngol Suppl (1977) 0.82

Bilateral congenital absence of the stapes and cervical spine anomaly. Am J Otol (1982) 0.81

Alloantigen-induced anti-HIV activity occurs prior to reverse transcription and can be generated by leukocytes from HIV-infected individuals. Blood (2000) 0.81

Q fever meningoencephalitis in a soldier returning from the Persian Gulf War. Clin Infect Dis (1993) 0.81

Cerebellar and cerebral electroencephalogram during the high pressure nervous syndrome (HPNS) in rats. Undersea Biomed Res (1977) 0.81

Folie à deux: three cases in the elderly. Int Psychogeriatr (1997) 0.80

Atrial dysrhythmia and atrial secundum defects. J Thorac Cardiovasc Surg (1969) 0.80

Pseudoepidemic of Aspergillus niger infections traced to specimen contamination in the microbiology laboratory. J Clin Microbiol (1999) 0.80

Treatment of radiation-induced tissue injury by hyperbaric oxygen. Ann Otol Rhinol Laryngol (1979) 0.80

The inositol phosphate pathway as a mediator in the proliferative response of rat calvarial bone cells to cyclical biaxial mechanical strain. J Orthop Res (1992) 0.80

Incubator noise and possible deafness. Arch Otolaryngol (1973) 0.79

Anti-CCR5 antibodies in sera of HIV-positive individuals. Hum Immunol (2001) 0.79

Localization of the tube precipitin and complement fixation antigens of Coccidioides immitis by immunoelectron microscopy with murine monoclonal antibodies. Infect Immun (1992) 0.79

Chronic mucormycosis. Laryngoscope (1982) 0.79

Ototoxic drug effects on cochlear histochemistry. Arch Otolaryngol (1973) 0.79

Submaxillary gland tumors. Laryngoscope (1974) 0.78

Inner ear decompression sickness. Laryngoscope (1976) 0.77

Adolescent running away behavior: active or passive avoidance? J Genet Psychol (1994) 0.77

Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease: contribution of HIV-1 RNA and T lymphocyte subset quantitation. Mil Med (2001) 0.77

The effect of noise trauma following training exposures in the mouse. Hear Res (1995) 0.77

Perilymph pressure during hypobaric conditions--cochlear aqueduct obstructed. Acta Otolaryngol (1994) 0.76

Measurement of cerebrospinal fluid antibody to the HIV-1 principal neutralizing determinant (V3 loop). J Acquir Immune Defic Syndr (1993) 0.76

Disaster management. Organizations and academic perspective. Crit Care Clin (1991) 0.76

Cerebrospinal fluid neopterin levels in 159 neurologically asymptomatic persons infected with the human immunodeficiency virus (HIV-1): relationship to immune status. Viral Immunol (1993) 0.75

Hypothermia and extracorporeal rewarming: the journey toward a less invasive, more accessible methodology. Crit Care Med (1998) 0.75

Resuscitation access and assessment: recurring themes of the intraosseous route. Crit Care Med (2000) 0.75

Presence of neutralizing antibodies to heterologous human immunodeficiency virus type 1 isolates in sera of infected individuals is not predictive of rate of disease progression. Clin Diagn Lab Immunol (1995) 0.75

Heatstroke: community prevention and prospective immunotherapeutic interventions. Crit Care Med (1997) 0.75